DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20221750

Post-COVID-19 manifestations-are they a matter of concern?

Deepak Rajan, Ameena Subair Raheela, Preetha Muduvana, Sachin Kuthirummal Chirammal, Anitha Subhadra Saraswathy, Bhagyalakshmi Choorickadu, Vismaya Pattarkatt Puthiya Purayi, Chathurya Chelangara, Akshay Mullan, Akshay Chandran, Shanil Ariyeri, Lenin Thazhe Kandiyantavida

Abstract


Background: COVID-19 is an infectious disease caused by a new coronavirus (SARS CoV-2) which may seriously affect the respiratory system. Global data shows 80% of the patients suffer from mild symptoms such as fever, dry cough and fatigue. 87.4% of COVID-19 patients reported persistence of at least one symptom after recovery. The aim of the study was to estimate the prevalence of Post COVID-19 Manifestations (PCM) and its determinants among those declared positive for SARS-CoV-2 in Kannur district of Kerala.

Methods: A cross-sectional study was carried out among COVID-19 recovered individuals who were tested positive for SARS-CoV-2 during the period from March 2020 to September 2020 in Kannur district. Study participants were contacted over phone and details collected were entered into Microsoft excel and analysed using Stata 14.4. Descriptive analysis, chi-square test and binary logistic regression were used to interpret the data.

Results: The prevalence of PCMs among the study population was found to be 19.5%. The most common type of PCM reported was loss of taste. Major predictor variables of the outcome were symptom status during testing for COVID-19, hospital admission for COVID-19 treatment and excessive fatigue.

Conclusions: The study found that PCMs occurred in about one-fifth of the study population. Considering the burden of PCMs among the study population, this study provides rationale for strengthening and sensitization of primary health care providers and the general public for the identification and management of PCMs.


Keywords


COVID-19, Kerala, Post-COVID -19 manifestations, Prevalence

Full Text:

PDF

References


Goenka A, Liu L. Infectious diseases, human capital and economic growth. Econ Theory. 2020;70(1):1-47.

Hua J, Shaw R. Corona Virus (COVID-19) “Infodemic” and Emerging Issues through a Data Lens: The Case of China. Int J Environ Res Public Health. 2020;17(7):E2309.

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet Lond Engl. 2020;395(10223):470-3.

Nature. COVID-19: a new challenge for human beings, Cellular and Molecular Immunology,2021. Available at: https://www.nature.com/articles/s41423-020-0407-x. Accessed on 10 September 2021.

Bulletin HFWD English September 28. Available at: https://dhs.kerala.gov.in/09/Bulletin-HFWD-English-September-28.pdf. Accessed on 22 March 2021.

Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020 Sep 1;174(9):882-889.

Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness-PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/16631/. Accessed on 22 March 2021.

Coronavirus disease (COVID-19): How is it transmitted? Available at: https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-his-it-transmitted. Accessed on 22 March 2021.

Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health. 2021;15:8.

Long-term Health Consequences of COVID-19, Cardiology, JAMA. JAMA Network. Available at: https://jamanetwork.com/journals/jama/fullarticle/2771581. Accessed on 22 March 2021.

Carfì A, Bernabei R, Landi F. For the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5.

Late Sequelae of COVID-19, CDC. Available at: https://www.cdc.gov/coronavirus/2019ncov/hcp/clinical-care/late-sequelae.html. Accessed on 22 March 2021.

Guidelines Post COVID Clinics. Available at: https://dhs.kerala.ontent/uploads/2020/10/Guidelines-Post-COVID-Clinics.pdf. Accessed on 23 March 2021.

14. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network-United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8.

Song W-J, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. The Lancet Respiratory Medicine. 2021;9(5):533-44.

Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10-12.

Cipriani G, Danti S, Nuti A, Carlesi C, Lucetti C, Di Fiorino M. A complication of coronavirus disease 2019: delirium. Acta Neurol Belg. 2020;1-6.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32.

Sultana S, Islam MT, Salwa M, Hossain SMZ, Hasan MN, Masum AA et al. Duration and Risk Factors of Post-COVID Symptoms Following Recovery Among the Medical Doctors in Bangladesh. Cureus. 2021;13(5).